A comparative study of blood-based KRAS mutation analysis in circulating tumor cells versus circulating plasma DNA to predict primary tumor mutations in lung cancer.


Autoria(s): Lim, E.K.S.; Freidin, M.B.; Freydina, D.V.; Chudasama, D.; Leung, M.; Popat, S.; de Castro, D.G.; Rice, A.; Anikin, V.; Fernandez, A.M.; Nicholson, A.G.
Data(s)

20/05/2014

Identificador

http://pure.qub.ac.uk/portal/en/publications/a-comparative-study-of-bloodbased-kras-mutation-analysis-in-circulating-tumor-cells-versus-circulating-plasma-dna-to-predict-primary-tumor-mutations-in-lung-cancer(d148ba62-14b0-4b9e-bf0a-94f977e2cfc5).html

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Lim , E K S , Freidin , M B , Freydina , D V , Chudasama , D , Leung , M , Popat , S , de Castro , D G , Rice , A , Anikin , V , Fernandez , A M & Nicholson , A G 2014 , ' A comparative study of blood-based KRAS mutation analysis in circulating tumor cells versus circulating plasma DNA to predict primary tumor mutations in lung cancer. ' .

Tipo

conferenceObject